-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XB-002 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XB-002 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XB-002 in Endometrial Cancer Drug Details: XB-002 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABBV-706 in Oligodendroglioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABBV-706 in Oligodendroglioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABBV-706 in Oligodendroglioma Drug Details: ABBV-706 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NC-410 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NC-410 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NC-410 in Ovarian Cancer Drug Details: NC-410 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NC-410 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NC-410 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NC-410 in Endometrial Cancer Drug Details: NC-410 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NC-410 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NC-410 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NC-410 in Solid Tumor Drug Details: NC-410 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NC-410 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NC-410 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NC-410 in Colorectal Cancer Drug Details: NC-410 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ICIP in Skin Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ICIP in Skin Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ICIP in Skin Cancer Drug Details: iCIP is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PAC-1 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PAC-1 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PAC-1 in Solid Tumor Drug Details: PAC-1 (also known as VO-100)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LOXO-783 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LOXO-783 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LOXO-783 in Solid Tumor Drug Details: LOXO-783 (LOX-22783) is under development...